Pre-clinical development of an enzyme replacement therapy (CPI-601) for CLN1 Batten disease: process development, stability and uptake studies in different species - Renuka Raman, Ph.D.; Ben Horst, Ph.D.; Maryam Zare, Ph.D.; Zahra Shajrokh; Magdalena Leszczyniecka, Ph.D.; Sean Ekins, Ph.D., D.Sc (Neurotherapeutics)